The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Comparing the impact of dose reductions and delays on ovarian cancer patient outcomes with three-weekly versus dose dense carboplatin and paclitaxel regimens in the national prospective OPAL cohort.
 
Tharani Sivakumaran
No Relationships to Disclose
 
Linda R. Mileshkin
Travel, Accommodations, Expenses - BeiGene; Roche; Roche
 
Peter T. Grant
Research Funding - Clovis Oncology (Inst)
 
Michael Friedlander
Honoraria - AstraZeneca; MSD
Consulting or Advisory Role - AstraZeneca; MSD
Research Funding - BeiGene (Inst)
 
Penelope M Webb
Research Funding - AstraZeneca (Inst)
 
George Au-Yeung
No Relationships to Disclose